Sljedeći

Auto Play

Chemotherapy Toxicity Considerations in Soft Tissue Sarcoma

0 Pogledi • 07/18/23
Udio
Ugraditi
administrator
administrator
Pretplatnici
0

The panelists, Brian Van Tine, MD, PhD; Robin Jones, MD, MRCP; Andrew Wagner, MD, PhD; Lor Randall, MD, FACS; Shreyaskumar Patel, MD; and Jonathan Trent, MD, PhD; discuss the factors they consider when balancing the risks and benefits of chemotherapy treatment in soft tissue sarcoma.

Prikaži više
0 Komentari sort Poredaj po
Komentari na Facebooku

Sljedeći

Auto Play